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Highlights 
 Self-management is one’s ability to manage the condition, treatments, roles and life-
styles 
 Self-management is recommended in national guidelines for managing chronic pain 
 However there is no consensus to measuring self-management in chronic pain 
 This systematic review identified 14 diverse measures used to assess self-management 
 Multi-dimensional measures are suitable for measuring self-management 
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ABSTRACT  
Objectives: The aim of this review was to identify, appraise and synthesise the outcome 
measures used to assess self-management in patients with chronic pain. 
Methods: Medline, Embase, CINAHL, PsycINFO, the Cochrane Library and Google Scholar 
were searched to identify quantitative measures used within randomised or non-randomised 
clinical trials to assess self-management in adults (≥18 years) with chronic pain. 
Results: 25 RCTs published between 1998 and 2016 were included in this review. Studies 
included patients with chronic pain, hip/knee osteoarthritis, rheumatoid arthritis, chronic low 
back pain, fibromyalgia and chronic fatigue syndrome. Included studies utilised 14 different 
measures assessing a variety of constructs including self-efficacy (n=19), coping (n=4), 
empowerment (n=2), pain attitude and management (n=3), self-care (n=1), role behaviour 
(n=1) and multiple constructs of self-management (n=1). The Chronic Pain Coping Inventory 
(CPCI) and Health Education Impact Questionnaire (heiQ) cover different self-management 
related constructs across the physical, mental and social health domains. 
Conclusion: The review identified 14 measures used as proxy measure to assess self-
management in patients with chronic pain. These measures have good content and construct 
validity, and internal consistency. However additional research is required to develop their 
reliability, responsiveness and interpretability.  
Practice implications: Multi-constructs measures (CPCI, heiQ) are suitable assess self-
management. 
Keywords: self-management, chronic pain, systematic review, outcome measures 
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1. Introduction 
Chronic pain is a common [1,2] and challenging condition associated with high healthcare 
usage [3] and socioeconomic burden [4,5]. Given the known benefits in reducing pain and 
disability [6,7], the clinical practice guidelines [8-10] recommend self-management for chronic 
pain along with other treatments. Self-management (SM) is one’s dynamic ability to manage 
the chronic condition and its treatment, adapt to physical and psychological changes, and 
adhere to lifestyle modifications [11]. SM involves a number of constructs, which include 
managing the disease, healthy lifestyle behaviours, changes in social and vocational roles and 
emotion by solving day-to-day problems, making conscious decisions, using appropriate health 
and social care resources, forming a good relationship with the health care providers and 
importantly taking appropriate actions [12,13], for example, pacing or increasing physical 
activity. 
Measuring the effectiveness of an intervention to enhance SM (called SM support) in chronic 
conditions is complex and widely variable [14]. Change in SM in chronic pain is predominantly 
measured using a wide range of outcome measures for pain, physical functioning, 
psychological wellbeing and quality of life, which are not designed specifically to measure 
SM. Different scales are commonly employed to measure SM for example, Arthritis Self-
Efficacy Scale [11], Patient Activation Measure (PAM) [15] and the Health Education Impact 
Questionnaire (heiQ) [16]; however, there is currently no standardised way of measuring SM. 
National clinical practice guidelines do not recommend the use of any particular scale/ tool for 
measuring SM [17]. AC
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Therefore, the purpose of this systematic review was to identify, appraise and synthesise the 
range of outcome measures used to assess self-management (SM) in patients with chronic pain- 
aiming to provide information that will help researchers and clinicians in the selection of the 
most appropriate tool to assess SM. 
2. Methods 
The review was conducted following the published protocol [18]. Additionally, Patient 
Reported Outcome Measure Information System (PROMIS) framework [19], which is based 
on World Health Organization’s physical, mental and social health categories [20], was used 
in the review to appraise the domains or ‘latent traits’ targeted by the measures assessing SM. 
Further, modified Terwee criteria [21] were utilised to summarise the psychometric properties 
of the included measures. These criteria were developed to provide explicit guidance for 
assessing the quality of health questionnaires.  
2.1. Search strategy 
Medline, Embase, CINAHL, PsycINFO, the Cochrane Library (since inception to February 
2016) and Google Scholar were electronically searched. The search strategy was developed 
with a combination of Medical Subject Headings and keywords, using randomised controlled 
trial (RCT) filters from the Cochrane Back Review Group [22]. Further, the references of 
selected articles were hand-searched for eligible studies and experts in the area of SM research 
were contacted for any potential additional unpublished studies. AC
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2.2. Inclusion criteria of studies 
Full-text primary research reports (available in English language) of randomised and non-
randomised controlled trials were included, where effectiveness of any non-surgical 
interventions was purposefully measured with quantitative outcome measures to assess SM in 
adult (more than 18 years with no upper age limit) patients with chronic pain (at least three 
months duration) (Table 1). Given this review targeted outcome measures used to assess SM, 
studies reporting outcomes of non-surgical interventions were considered for inclusion, 
including SM support programmes, educational interventions, physical, psychological, 
cognitive therapy, cognitive-behavioural therapy, behavioural therapy and their combinations. 
SM defines individuals’ ability to manage chronic pain, its treatments and physical, mental and 
social changes [11].  
2.3. Exclusion criteria of studies 
Studies involving participants with carcinoma, episodic pain (including post-surgical pain), 
traumatic and surgical conditions, substance abuse and addiction, AIDS and end-of-life care 
conditions (or terminal illnesses) were excluded because of the difference in the nature of pain 
and variation in the motivational factors associated with self-regulation of pain. Validation and 
feasibility studies that were not designed to investigate change in SM were excluded in this 
review. Book chapters, stand-alone abstracts, opinions and correspondence and previous 
reviews were excluded from the review, as these are not primary research reports. Studies 
published in languages other than English were excluded due to limited resources and unclear 
advantage of inclusion of non-English language research reports [23]. As the review aimed at 
appraising the outcome measures utilised, secondary research reports were excluded to avoid 
multiple publication bias (Table 1). 
Please insert Table 1 about here 
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2.4. Selection of studies 
The Cochrane Handbook [23] and the Cochrane Back Review Group [22] guidelines were 
followed in the review process. The review findings are reported in keeping with The Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [24]. Electronic search 
yields were imported into an Endnote file. After deleting duplicates, potential studies were 
screened at two stages- firstly, at brief screening by titles and abstracts, and finally, at detailed 
screening, by reading full text articles. Articles were screened by two independent reviewers 
(AB and PB) for inclusion in the review. Any disagreement in study selection were resolved 
by consensus or by consulting a third reviewer (PH or HB). The reasons for exclusion were 
reported only at full-text screening stage. 
2.5. Risk of bias assessment of the selected studies 
Two reviewers (AB and PB) assessed quality of the individual studies using the Cochrane Risk 
of Bias tool [23]. The Cochrane Risk of Bias assessment tool guides the reviewers to rate 
selection bias, performance bias, detection bias, attrition bias and reporting bias in ‘low risk’, 
‘high risk’ and ‘unclear risk’ categories. Disagreements were resolved by consensus or by 
consulting a third reviewer (PH or HB). 
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2.6. Data extraction 
One reviewer (AB) extracted study details (type of study, aims and sample size), population 
characteristics (age, gender, level of education, employment status, condition, symptoms 
duration), SM outcome measures (name, constructs measured, source and psychometric 
properties reported in the selected studies) and other outcome measures (for example, pain, 
disability, disease severity). Further, characteristics of the interventions including SM support 
programmes (description, mode of delivery, duration and follow-up) were extracted. A second 
reviewer (PB) verified the extracted data.  
Psychometric properties of the included outcome measures were extracted by the first reviewer 
(AB) from three sources: the individual articles, relevant citations and additional search in Ovid 
Medline (1996 to present). Extracted psychometric data were verified with the source by a 
second reviewer (PB) at random 50% of the fields.  Psychometric properties of these included 
measures were reported using a modified criteria following Terwee and colleague [21]. The 
criterion validity was not assessed in absence of a ‘gold standard’ measure for assessing change 
in SM. Any disagreement in data extraction was resolved by discussion. 
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3. Results 
3.1. Study selection 
A total of 2383 search yields were imported into Endnote, where duplicates were deleted.  1633 
reports were screened by title and abstract and 110 reports were selected for full text review. 
85 studies were excluded after reading full-text versions (reasons outlined in Table 2) and 25 
studies were included in this systematic review.  The PRISMA flow diagram is presented in 
Figure 1. All included 25 studies were RCTs published between 1998 and 2016 and conducted 
in Western developed countries (USA, Canada, Australia, Germany, Switzerland, Sweden, 
Norway, Belgium and UK). 
Please insert Table 2 about here 
Please insert Figure 1 about here 
3.2. Risk of bias assessment of the selected studies 
The majority of included studies were categorised with ‘low risk' for selection bias, detection 
bias, attrition bias and reporting bias. However, overall a high risk of performance bias was 
found in the majority of included studies, as blinding of the personnel and patients were not 
attempted due to practical reasons in a majority of the individual studies. Baseline differences 
in the clinical and demographic details among the treatment groups were low risk in the 
majority of the included studies. Details of the risk of bias assessment are summarised in 
Figures 2 and 3. 
Please insert Figure 2 and Figure 3 about here 
AC
CE
PT
ED
 M
AN
US
CR
IPT
10 
 
3.3. Participants 
The sample sizes in the selected studies ranged between 30 [25] and 812 [26]. The participants 
in the selected studies were patients with hip/knee osteoarthritis and/or rheumatoid arthritis (six 
studies) [26-31], chronic low back pain (six studies) [32-37], fibromyalgia (two studies) 
[25,38], chronic fatigue syndrome (one study) [39] and non-cancer chronic musculoskeletal 
pain (seven studies) [40-46].  The mean age of participants in the individual studies ranged 
from 39 [42] to 82 years [41]. The average duration of symptoms in the included studies varied 
from three years [32] to over 13 years [27]. Characteristics of the participants in the included 
studies are presented in Table 3. 
Please insert Table 3 about here 
3.4. Interventions 
13 of the included studies evaluated the effectiveness of physical activity programmes [32], 
behavioural interventions [27,33,39,43,45], pain education programmes [25], their 
combinations [28,35,37,49], and others non-surgical treatments [31,47]. The remaining 12 
studies investigated the effectiveness of SM support programmes. The SM programmes were 
delivered in face-to-face group settings in nine studies [26,29,34,38,40-42,44,48], and online 
in three studies[30,36,46]. All SM support programmes were carried out at outpatient clinics 
except one study [50], which was in a specialised inpatient setting. The duration of the 
programmes ranged from 2.5 hours [34] to 16 hours [44]. The follow-up period in the 
individual studies ranged from three weeks to 12 months. AC
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3.5. Self-management outcome measures 
This systematic review identified 14 different scales used to assess change in SM (Table 4). 
The majority of the included studies used self-efficacy scales as a proxy measure of SM with 
other measures for pain, physical function and psychological wellbeing. 
Please insert Table 4 about here 
3.5.1. Self-Efficacy Scales 
Arthritis Self-Efficacy Scale (ASES) was used in six of the included studies [26,27,29-31,38]. 
The ASES was developed by Lorig and colleague in late 1980s [51] to measure a patient’s 
perceived self-efficacy or confidence to cope with specific arthritis symptoms or activity. This 
20-item scale measures three SM constructs: pain self-efficacy (five items), function self-
efficacy (nine items) and other symptoms self-efficacy (six items). Each item can be rated on 
a 10-point scale from ‘1 (or 10) = very uncertain’ to ‘10 (or 100) = very certain’. This scale has 
acceptable internal consistency (Cronbach’s α 0.82-0.91) and been widely used in patients with 
osteoarthritis [52]. 
Self-Efficacy Scale (SES) was utilised in three included studies [28,34,42]. This 11-item scale 
was developed by using pain and other symptoms subscales of the original ASES. Each item 
can be rated using a 10-point graphic/ numeric rating for example, ‘1 (or 10) = very uncertain’ 
to ‘10 (or 100) = very certain’. The phrase ‘arthritis pain’ is usually changed according to the 
specific disease population, for example, ‘chronic pain’ or ‘back pain’. The internal consistency 
(Cronbach’s α 0.82-0.91) has been estimated at 0.76 to 0.90 [42,51]. AC
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Pain Self-Efficacy Questionnaire (PSEQ) was used in seven included studies [33,37,44-
46,48,49]. This 10-item scale was developed by Nicholas and colleague [53] in the late 1980s 
to measure a patient’s perceived confidence in performing specific activities when living with 
pain. Each of these items are rated with a 7-point Likert scale where ‘0 = not at all confident’ 
and ‘6 = completely confident’. Internal consistency (Cronbach’s α 0.82-0.91) was estimated 
at 0.92 [53]. 
Chronic Pain Self-Efficacy (CPSE) scale was utilised in one included study [47]. This 22-item 
scale was developed to measure self-efficacy in patients with chronic pain [54]. Each item can 
be scored from 0 to 8. The original scale has three subscales: pain management self-efficacy 
(PSE), coping self-efficacy (CSE) and physical function self-efficacy (FSE) with internal 
consistency (Cronbach’s α) 0.88, 0.90 and 0.87 respectively [54]. The included study used only 
the PSE subscale. 
The Health Related Behaviour Self Efficacy and Body Self Efficacy Scale[55] were used in 
one included study.[32] These scales have a reported internal consistency (Cronbach’s α) of 
0.76 and 0.72 respectively [55]. Jason and colleague [39] used a self-efficacy scale with a 5-
point Likert scale option (completely disagree to completely agree) modified for patients with 
chronic fatigue syndrome. This scale has an internal consistency (Cronbach’s α) ranging from 
0.70 to 0.77 [56]. 
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3.5.2. Coping Scales 
The Coping Strategies Questionnaire (CSQ) scale was used in two included studies [31,43]. 
The original 50-item scale was developed in patients with chronic low back pain. Each item 
can be rated from ‘0 = never do that’ to ‘6 = always do that’ [57]. This scale measures how 
frequently the six cognitive coping strategies (ignoring pain, reinterpretation, diverting 
attention, self-statements, catastrophizing, praying/ hoping) and two behavioural coping 
(increasing activity and increasing pain behaviour- overt pain behaviours that decrease pain) 
are used and with two single item questions on how effective each of these coping strategies is 
in controlling and decreasing pain [58]. Despite the factor instability [59], this scale measures 
three main constructs: conscious cognitive coping attempts, confidence in controlling and 
decreasing pain and diverting attention in non-painful activities [58]. Internal consistency of 
CSQ was estimated between 0.45 and 0.84 [59]. 
The Pain Coping Inventory (PCI) was utilised in one study [25]. This 34-item scale measures 
three active coping strategies (transformation, distraction and reducing demands) and three 
passive coping strategies (ruminating, retreating and resting). Each item can be rated from ‘1 
= hardly ever’ to ‘4 = very often’. The PCI is reliable with internal consistency (Cronbach’s α 
0.82-0.91) for subscales (in people attending pain clinic) between 0.53 and 0.83 [60]. 
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The 42-item Chronic Pain Coping Inventory was used in one included study [30] along with 
the ASES. The CPCI was developed and validated in chronic pain population by Jenson and 
colleague [61,62] to measure cognitive and behavioural coping. The CPCI includes 8 sub-
scales: three on illness focused coping: Guarding, Resting, Asking for Assistance; four on 
wellness focused coping: Relaxation, Task Persistence, Exercises and Stretch, Coping Self-
statements; and other coping Seeking Social Support. Items are rated from ‘0 to 7’ as these are 
used in last one week. This scale provides individual sub-scale scores but does not provide a 
composite score. This scale is a modified version of an earlier 65-item scale [61]. The 42-item 
scale demonstrates good reliability and internal consistency (Cronbach’s α) 0.71-0.89 [62]. 
3.5.3. Pain Attitudes and Management Scales 
The Survey of Pain Attitudes (SOPA) scale was used in two included studies [33,41]. This 
scale has seven subscales: Control, Disability, Harm-exercise (accepts pain means damage and 
activity can increase damage), Emotion, Medication, Solicitude and Medical Care. Items can 
be rated with ‘0 = very untrue for me’ to ‘4 = very true for me’. The longer version of the scale 
[63] has 57 items but a reduced version with 30 items is also available [64]. The original scale 
has moderate internal consistency (Cronbach’s α 0.71-0.80 for long version [63] and 0.56-0.83 
for short version) [64]. 
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The German Pain Management Questionnaire (GPMQ) was used in one included study [35]. 
This scale consists of 24 items and each item can be rated from ‘1 = do not agree at all’ to ‘6 = 
fully agree’. This scale has two main domains: a) cognitive strategies consisting of three 
subscales: action-oriented coping, cognitive restructuring and coping competence and b) 
behavioural strategies consisting of three subscales: mental distraction, counter activities and 
relaxation. Each of these subscales can be scored between 4 and 24, where a higher score 
indicates stronger agreement with the respective coping strategy. The internal consistency 
(Cronbach’s α) of these subscales range from 0.73 to 0.84 [35]. 
3.5.4. Empowerment Scales 
The Psychological Empowerment Scale (PES) was utilised in one study [36]. This scale was 
originally developed following the Cognitive Empowerment Model in a workplace setting [65] 
and later utilised in patients with fibromyalgia syndrome [66]. This scale has four different 
subscales: meaningfulness, competence, self-determination and impact; each subscale has 
three items, which can be scored using a 7-point Likert scale from ‘1 = strongly disagree’ to ‘7 
= strongly agree’ [36,67]. Each of these subscales has acceptable internal consistency 
(Cronbach’s α 0.87-0.97) [66]. In the included study, the PES was translated and contextualised 
for Italian patients with chronic back pain and a similar internal consistency (Cronbach’s α 
0.82-0.91) for the translated version was reported between 0.71 and 0.94 [36]. 
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The Swedish Rheumatic Disease Empowerment Scale (SEW-RES-23) was used in one 
included study [40]. This 23-item scale measures five constructs: goal achievement and 
overcoming barriers, self-knowledge, stress management, assessing dissatisfaction and 
readiness to change, and support for caring. Each item can be rated from ‘1 = strongly disagree’ 
to ‘5 = strongly agree’ and a higher total score indicates better empowerment. The Diabetes 
Empowerment Scale [68] was translated into Swedish for patients with diabetes [69]. This 
Swedish scale was later modified and validated in the SWE-RES-23 for patients with rheumatic 
diseases [70]. The estimated internal consistency (Cronbach’s α) ranged from 0.59 to 0.91 for 
the five sub-scales and 0.92 for the total score [70]. The SEW-RES was used with the Appraisal 
of Self Care Agency scale in the included study [40]. 
3.5.5. Other Scales 
Appraisal of Self Care Agency Scale (ASA-A) was utilised to assess the self-care ability in one 
included study [40]. This scale contains 24 questions and each item can be rated from ‘1 = 
totally disagree’ to ‘5 = totally agree’ [71] with a total possible score between 24 and 120, 
where higher scores indicate better self-care ability. The Swedish ASA-A has an internal 
consistency (Cronbach’s α 0.82-0.91) of 0.59 [72]. However, the ASA scale rated by caregivers 
or nurses has higher internal consistency (Cronbach’s α 0.77 or 0.87 respectively) [72].  
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The Social Integration and Support subscale of the Health Education Impact Questionnaire 
(heiQ) was used in one study [49]. This 40-item scale was purposefully designed for measuring 
SM and the development was guided by a Programme Logic Model, Concept Mapping and 
interviewing the stakeholders [73]. This scale consists of eight different independent 
constructs:  Positive and Active Engagement in Life (five items), Health Directed Behavior 
(four items), Skill and Technique Acquisition (five items), Constructive Attitudes and 
Approaches (five items), Self-Monitoring and Insight (seven items), Health Service Navigation 
(five items), Social Integration and Support (five items), and Emotional Wellbeing (six items). 
The Internal consistency (Cronbach’s α) of these sub-scales ranges between 0.70 and 0.89 [73]. 
Each of the 40 items can be scored on a four point Likert scale from ‘strongly disagree’ to 
‘strongly agree’. This scale does not provide a total score. However, the included study [49] 
used only one of these eight constructs along with PSEQ to measure self-management. 
The Inventory of Adult Role Behaviours (IARB) was used in one study [42] to assess self-help 
along with Self-Efficacy Scale. This 45-item scale [74] includes a modified 22-item Effect 
Scale [75] and 23 newly developed items on social, family, leisure and personal roles. Each 
item can be rated with a 100 mm visual analogue scale. This scale has excellent internal 
consistency (Cronbach’s α) 0.84-0.92 [74,75]. 
3.6. Constructs of the measures 
Further, the Patient Reported Outcome Measure Information System (PROMIS) framework 
[20] was used to evaluate the constructs or sub-scales of the identified SM measures (Table 5). 
Twelve out of 14 measures did not assess all three domains of the PROMIS. However, the 
Chronic Pain Coping Inventory (CPCI) and Health Education Impact Questionnaire (heiQ) 
cover all three PROMIS domains. 
Please insert Table 5 about here 
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3.7. Psychometric properties of the measures 
Psychometric properties of these included measures were summarised (in Table 6) following 
Terwee and colleague [21]. The content validity was established as positive or intermediate in 
10 out of 13 measures and nine measures had high internal consistency (Cronbach’s ) between 
0.70 and 0.95 with each of the sub-scales and/or the total scores. Only eight measures for 
construct validity and four measures for reliability had positive or intermediate ratings. 
Agreement, responsiveness, and floor and ceiling effects had no or negative ratings for all 13 
measures. Intermediate quality of interpretability was reported for only two out of 13 measures. 
These findings highlight, a lack of research in reproducibility, responsiveness and 
interpretability data for these outcomes. Further, Arthritis Self-efficacy Scale (ASES), Self-
Efficacy Scale (SES), Pain Self Efficacy Questionnaire (PSEQ), Chronic Pain Self-Efficacy 
Scale (CPSES), Chronic Pain Coping Inventory (CPCI) and Health Education Impact 
Questionnaire (heiQ) had better psychometric properties than the other included scales (with 
three or more positive ratings out of eight assessed- in Table 6). Among these six scales CPSES, 
CPCI and heiQ were developed either for patients with any condition or with chronic pain. 
Please insert Table 6 about here 
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4. Discussion and conclusion 
4.1. Discussion 
To date, this systematic review identified, synthesised and appraised the outcome measures 
used to quantify change in self-management (SM) in patients with chronic pain. The present 
review identified 25 randomised controlled trials with 14 different patient reported measures 
used to detect change in SM. These 14 measures are quite diverse and measure a variety of 
underlying constructs including self-efficacy, coping, empowerment and impact on knowledge. 
This demonstrates a lack of consistency and consensus around the measurement of SM in 
chronic pain and creates challenges in directly comparing findings of studies assessing SM or 
related constructs. It is evident that only effects measured by identical instruments can be 
directly compared. 
Our findings are in alignment with a prior systematic review by Boger and colleague [84] on 
patient reported outcome measures used in SM trials in patients with stroke. Boger and 
colleague found that multiple measures were used to capture change in SM. They also reported 
that the majority of their included studies (n=13) measured diverse constructs such as physical 
function, mood, participation, satisfaction and quality of life, which are not direct measures of 
SM. In their review, other commonly used proxy measures of SM (such as resource utilization, 
self-efficacy, locus of control, health behaviours, knowledge and goal attainment) were not 
frequently measured. However, this is not consistent with our review findings for SM in 
chronic pain, since the majority of our included studies used self-efficacy scales as a proxy 
measure of SM. AC
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Studies included in the current review frequently used more than one scale to capture SM, 
perhaps due to a lack of validated multi-domain SM scales. Theoretically, SM encompasses 
multiple constructs including; disease and symptoms management, behaviour management, 
role and emotional management [11] using problem solving and decision making skills, 
navigating health and care resources and taking appropriate actions (e.g., pacing or increasing 
physical activity) [12,85]. A recent systematic review on self-management in chronic low back 
pain has highlighted that the majority of included self-management trials did not disclose or 
follow a priory theoretical model or framework  [85]. Future research should aim to select and 
follow a theoretical framework for interventions which will inform selection of appropriate 
outcome measures. 
Conceptually, the constructs of SM fall into a range of constructs of the physical, mental and 
social health domains of Patient Reported Outcome Measure Information System (PROMIS) 
framework [20]. 12 of 14 measures did not assess all three domains of the PROMIS, which 
potentially make these measures less effective to detect changes in SM over time. In contrast, 
the CPCI and heiQ, covering all three PROMIS domains, are potentially more appropriate than 
scales measuring individual constructs of SM. 
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Another potential reason for the complexity in measuring SM in chronic pain is a lack of direct 
biological measures for pain severity [14,86]. In some chronic conditions, direct biological 
measures are available to detect change in disease severity, for example, HbA1c is commonly 
used to detect clinical changes in diabetes over time that are indicative of improvements in 
condition management. A review by Nolte and colleague [14] found outcome measures used 
in SM trials are mainly perception- or evaluation-based patient reported outcome measures 
(PROMs), which require the responders to understand the questions, recall and process relevant 
information to answer and finally to form the response in keeping with the quality of life 
appraisal model [87]. Nolte and colleague also identified that self-efficacy scales, which are 
most frequently used in our included studies, have high response shifts with small differences 
in the effect sizes between intervention and control groups, indicating instability across time. 
In another review, Miles and colleague evaluated psychometric properties of five commonly 
used self-efficacy measures (Arthritis Self-Efficacy Scale, Self-Efficacy Scale, Chronic Pain 
Self-Efficacy Scale and Pain Self-Efficacy Questionnaire) in people with chronic pain [88]. 
They found these self-efficacy scales to have acceptable internal consistency and construct 
validity, although indicated further research is required on responsiveness and test-retest 
reliability of the self-efficacy scales. Their results are in agreement with our own review. 
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The current review found self-efficacy scales to be the most frequently used to measure change 
in SM. These scales were developed and validated in patients with arthritis and later modified 
for populations with chronic pain. Most of these scales are short, quick to administer in the 
clinic and easy to score [88]. However, these scales can only measure perceived confidence in 
doing specific things despite the pain; therefore there is a tendency that these are activity-
specific and lack universal appropriateness to patients with chronic pain in identifying how 
patients self-manage. The coping scales measure endorsement and frequency of different 
cognitive and behavioral strategies used to cope with chronic pain. However, these coping 
scales fail to capture issues of empowerment or pain management skills. 
The Health Education Impact Questionnaire (heiQ) and Chronic Pain Coping Inventory (CPCI) 
are multi-domain scales cover all three PROMIS domains and had good psychometric 
properties. The CPCI measures cognitive and behavioural coping in chronic pain and the heiQ 
measures effect of any educational or SM support programme in all patients. Knowing the heiQ 
covers eight out of 12 SM related constructs across all three PROMIS domains (Table 5) and 
with acceptable psychometrics (Table 6) has emerged as an appropriate scale to measure 
change in SM over time. 
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4.2. Strength and limitations 
This review identified the wide range of measures used to assess change in SM in chronic non-
cancer pain. It assessed both the quality of the included studies and the identified measures 
flowing published quality assessment criteria. The reviewers carried out a thorough search; two 
independent reviewers conducted the study selection and the quality assessment; and 
synthesised the majority of validated scales used to measure change in SM. It is possible that 
articles may have been missed due to the search strategy and selection criteria of the review. 
Although every effort was made to seek additional information from authors where required, 
not all attempts of communication with authors were successful. Furthermore, seven abstracts 
were not available in full text version; and non-English articles were not considered for 
inclusion. 
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4.3. Conclusion 
This review identified and evaluated the measures used to detect change in SM in patients with 
non-cancer chronic pain. Included measures are diverse, targeting different SM constructs, 
highlighting the complexity, inconsistency and lack of consensus in definitions of SM. Despite 
some evidence on internal consistency, content and construct validity these SM measures 
significantly lack research in three core psychometric properties: reproducibility, 
responsiveness and interpretability, which may be prioritised in future research. Whilst single 
construct scales are more commonly used, they do not cover multiple PROMIS domains which 
potentially make these measures less effective to detect changes in SM over time. Multi-
construct scales (for example, Chronic Pain Coping Inventory and Health Education Impact 
Questionnaire) are valid, internally consistent and cover multiple PROMIS domains. Future 
research should aim to gain consensus on constructs of SM, for example using a modified 
Delphi method; to develop a new multi-domain SM measure for use with patients who have 
chronic pain; and validating the new and/or existing scales in patients with chronic pain. 
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Figure legends 
 
Figure 1: PRISMA Flow Diagram 
 
Figure 2: Risk of bias summary: review authors' judgements about each risk of bias 
item for each included study 
 
 low risk of bias  unclear risk of bias  high risk of bias 
 
 
 
Figure 3: Risk of bias graph: review authors' judgements about each risk of bias item 
presented as percentages across all included studies 
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Table 1: Study selection criteria for the systematic review 
Selection criteria 
Inclusion criteria 
 Participants: adults (≥18 years) with chronic pain (pain duration ≥ 3 months) 
 Intervention: any non-surgical interventions 
 Comparison: any comparisons 
 Outcome: change in self-management measured using a composite quantitative 
outcome measure 
 Studies: randomised and non-randomised controlled trails 
 Limits: (full-text) research reports available in English language 
Exclusion criteria 
 Observational, validation, feasibility and qualitative studies 
 Studies including patients with cancer, trauma, surgical and episodic pain; substance 
abuse and addiction; AIDS and end-of-life care conditions (or terminal illnesses) 
 Secondary research and multiple publication 
 
 
Table 2: Reasons for exclusion at the detailed screening stage 
Reasons for exclusion Number of studies 
Not in chronic pain as defined in the protocol 30 
No self-management outcome measure used 16 
Not randomised or non-randomised controlled trials 19 
Study protocol 05 
Secondary analysis or multiple publication 08 
No full text available even through interlibrary loan services 07 
Total excluded articles at the full-text screening 85 
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Table 3: Characteristics of the included studies 
Author, year 
[reference] 
Total 
participants 
(drop out) 
Conditions Mean 
symptom 
duration* 
Mean 
age* 
Female 
(%) 
Attended 
college or 
university 
(%) 
Unemployed 
(%) 
Self-management 
outcome measures 
Arvidsson 
2013 [40] 
202 (40) Chronic pain/ 
fatigue 
NR 56.4 (7.2) 
IG, 55.2 
(13.2) CG 
71 IG, 73 
CG 
21 in IG, 
25 in CG 
NR Swedish Rheumatic 
Disease 
Empowerment Scale; 
Self-Care Agency 
Scale  
Blodt 
2014 [32] 
128 (14) Chronic low 
back pain 
2.7 (1.4) 
IG, 3.2 
(1.5) CG 
45.7 
(10.0) IG, 
47.7 
(10.8) CG 
90.6 IG, 
69.8 CG 
67.2 IG, 
55.6 IG 
0 Self-Efficacy Scale 
Broderick 
2014 [27] 
256 (27) Osteoarthritis- 
knee/hip 
13.95 
(10.63) IG, 
13.59 
(9.09) CG 
68.00 
(8.67) IG, 
66.37 
(10.26) 
CG 
74.4 IG, 
78.9 CG 
71.7 IG, 
73.1 CG 
78.9 IG, 60.3 
CG 
Arthritis Self-
Efficacy Scale, 
Coping Strategies 
Questionnaire 
Brosseau 
2012 [28] 
222 (100) Osteoarthritis- 
knee 
10.3 (9.26) 63.4 (8.6) 68.9 72.1 NR Self-Efficacy- Coping 
with symptoms, 
Confidence about 
doing things 
Buszewicz 
2006 [26] 
812 (193) Osteoarthritis- 
hip/knee 
NR 68.4 (8.2) 
IG, 68.7 
(8.6) CG 
63 IG, 63 
CG 
28 IG, 27 
CG 
NR Arthritis Self-efficacy 
Carpenter 
2012 [33] 
141 (32) Chronic low 
back pain 
8.64 (7.84) 42.5 
(10.3) 
83 54 NR Pain Self-efficacy 
Scale, Survey of Pain 
Attitudes 
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Author, year 
[reference] 
Total 
participants 
(drop out) 
Conditions Mean 
symptom 
duration* 
Mean 
age* 
Female 
(%) 
Attended 
college or 
university 
(%) 
Unemployed 
(%) 
Self-management 
outcome measures 
Ersek 
2003 [41] 
45 (6) Chronic pain NR 81.9 
(range 65-
94) 
87 75 NR Survey of Pain 
Attitudes 
Haas 
2005 [34] 
109 (8) Chronic low 
back pain 
NR 77.2 (7.7) 84.4 23.8 NA Self-Efficacy Scale 
Hamnes 
2012 [38] 
150 (32) Fibromyalgia 7.03 (7.21) 
IG, 6.13 
(6.53) CG  
45.4 (9.4) 
IG, 49.7 
(4.0) CG 
92 IG, 100 
CG 
24 IG, 21 
CG 
72 IG, 70.8 
CG 
Arthritis Self Efficacy 
Scale 
Jason 
2007 [39] 
114 Chronic fatigue 
syndrome 
43.8 NR 83.3 90.3 58.3 Self-Efficacy Scale 
LeFort 
1998 [42] 
110 (8) Chronic pain  6.5 (range 
1-28) IG, 
5.6 (range 
1-20) CG 
39 IG, 40 
CG 
74 IG, 75 
CG 
75 IG, 66 
CG 
63 IG, 66 CG Self-Efficacy Scale 
MacPherson 
2015 [47] 
517 (89) Chronic neck 
pain 
6 53.2 
(13.8) 
69 NR 39.8 Chronic Pain Self-
Efficacy 
Questionnaire 
Meng 
2011 [35] 
360 (91) Chronic low 
back pain 
NR 50.2 (7.6) 
IG, 49.5 
(7.7) CG 
65.2 IG, 
63.0 CG 
18.9 IG, 
25.5 CG 
9.2 IG, 8.8 
CG 
German Pain 
Management 
Questionnaire 
Miller  
2015 [48] 
102 (22) Chronic pain 10 
(median) 
53.4 
(13.5) 
73.5 32 IG, 21 
CG 
86 IG, 92 CG Pain Self-Efficacy 
Questionnaire 
Naylor 
2008 [43] 
51 (4) Chronic 
musculoskeletal  
pain 
11.5 (9.27) 46 (11.47) 86  70 NR Coping Strategy 
Questionnaire 
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Author, year 
[reference] 
Total 
participants 
(drop out) 
Conditions Mean 
symptom 
duration* 
Mean 
age* 
Female 
(%) 
Attended 
college or 
university 
(%) 
Unemployed 
(%) 
Self-management 
outcome measures 
Newman 
1991 [29] 
180 (50) Osteoarthritis, 
rheumatoid 
arthritis 
12.9 (1.49) 69.0 87.7 IG 59.2 
CG 57.6 
IG 1.4, CG 
0.0 
Arthritis Self Efficacy 
Scale 
Nicholas 
2013 [44] 
141 (22) Chronic pain 6.0 
(median) 
73.9 (6.5) 63 NR NA Pain Self-Efficacy 
Questionnaire 
Nicholas 
2014 [45] 
140 (13) Chronic pain 5.60 (7.26) 
IG, 6.48 
(7.44) 
42.05 
(12.33) 
IG, 43.22 
(11.08) 
CG 
51 IG, 55 
CG 
55 IG, 55 
CG 
68 IG, 70 CG Pain Self Efficacy 
Questionnaire 
Riva 
2014 [36] 
51 (0) Chronic back 
pain 
7.9 (7.2) 
IG, 9.3 
(8.7) CG 
44(13.6) 
IG, 
51(14.1) 
CG 
51.9 IG, 
50.0 CG 
33.3 IG, 
12.7 CG 
40.7 IG, 41.7 
CG 
Psychological 
Empowerment Scale 
Ryan 
2010 [37] 
38 (11) Chronic low 
back pain 
7.6 (7.0) 
IG, 13.7 
(10.2) CG 
45.2 
(11.9) IG, 
45.5 (9.5) 
CG 
70.0 IG, 
61.1 CG 
NR NR Pain Self Efficacy 
Questionnaire 
Taylor 
2016 [49] 
703 (82) Chronic 
musculoskeletal 
pain 
85% had 
pain for 3 
years or 
more 
60.3 
(13.5) IG, 
59.4 
(13.8) CG 
67 40% 
ended 
formal 
education 
after 20 
years 
26 IG, 24 CG Pain Self-Efficacy 
Questionnaire, Health 
Education Impact 
Questionnaire (Social 
Integration and 
Support) 
Trudeau 
2015 [30] 
245 (73) Arthritis and 
ankylosing 
spondylitis 
NR 49.9 
(11.6) 
68.4 61.4 8.8 Arthritis Self Efficacy 
Scale and Self-
Management 
Behaviours 
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Author, year 
[reference] 
Total 
participants 
(drop out) 
Conditions Mean 
symptom 
duration* 
Mean 
age* 
Female 
(%) 
Attended 
college or 
university 
(%) 
Unemployed 
(%) 
Self-management 
outcome measures 
Van 
Oosterwijck 
2013 [25] 
30 (4) Fibromyalgia 13.0 (6.0) 
IG, 9.67 
(3.83) CG 
45.8 (9.5) 
IG, 45.9 
(11.5) CG 
80 IG, 
93.3 CG 
NR 66.7 IG, 53.3 
CG 
Pain Coping 
Inventory 
Weiner 
2013 [31] 
190 (31) Osteoarthritis- 
knee 
5.7 (6.4) 
IG, 6.2 
(6.8) IG1, 
7.2 (8.3) 
CG 
67.1 (8.9) 
IG, 65.8 
(8.7) IG1, 
66.8 
(10.4) CG 
12.7 IG, 
15.6 IG1, 
17.5 CG 
58.7 IG, 
54.7 IG1, 
50.8 CG 
NA Arthritis Self Efficacy 
Scale 
Wilson 
2014 [46] 
114 (34) Chronic pain NR 49.33 
(11.63) 
78 51 NR Pain Self-Efficacy 
Questionnaire 
CG control group, IG intervention group, IG1 other intervention group, NA not applicable, NR not reported, * mean (standard deviation) in 
years unless mentioned 
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Table 4: Self-management outcome measures used in the included studies 
No. Name of the instrument  
(Number of studies which used the instrument) 
Number 
of items 
Scoring 
methods 
No of 
subscales 
Administration 
of the scales 
Internal 
consistency 
(Cronbach’s α 
) as mentioned 
in the 
included/ cited 
studies 
1. Arthritis Self-efficacy Scale (6) 20 10-point 3 Pen and paper 0.82-0.91 
2. Self-efficacy Scale (3) 11 10-point 1 Pen and paper 0.76-0.90 
3. Pain Self Efficacy Questionnaire (7) 10 7-point 1 Pen and paper 0.92 
4. Chronic Pain Self-Efficacy Scale (1)* 22 9-point 3 Pen and paper 0.87-0.90 
5. Coping Strategies Questionnaire (2) 50 7-point 8 Pen and paper 0.45-0.84 
6. Pain Coping Inventory (1) 34 4-point 6 Pen and paper 0.53-0.83 
7. Chronic Pain Coping Inventory (1) 42 0 to 7 days 8 Pen and paper 0.71-0.89 
8. Survey of Pain Attitudes (2) 30 5-point 7 Pen and paper/ 
online  
0.56-0.83 
9. German Pain Management Strategies (1) 24 6-point 6 Pen and paper 0.73-0.84 
10. Psychological Empowerment Scale (1) 12 7-point  4 Pen and paper/ 
online 
0.87-0.97 
11. Swedish Rheumatic Disease Empowerment Scale (1) 23 5-point 5 Pen and paper 0.59-0.91 
12. Appraisal of Self-Care Agency Scale (1) 24 5-point 1 Pen and paper 0.59-0.87 
13. Health Education Impact Questionnaire** (1) 40 4-point 8 Pen and paper/ 
telephone 
0.70-0.89 
14. Inventory of Adult Role Behaviours (1) 45 100 mm 
visual 
analogue 
scale 
2 Pen and paper 0.84-0.92 
* Pain Management Self-Efficacy subscale was used in the study. ** Social Integration and Support sub-scale was used in the study
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Table 5: Appraisal of the self-management measures following PROMIS framework [19] 
No. Measures Physical Psychological Social 
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1. Arthritis Self-efficacy Scale + - + - - - + - - - - - 
2. Self-Efficacy Scale + - + - - - + - - - - - 
3. Pain Self Efficacy Questionnaire + - + - - - + - - - - - 
4. Chronic Pain Self-Efficacy Scale + - + - + + + - - - - - 
5. Coping Strategies Questionnaire + - + + + + + - - - - - 
6. Pain Coping Inventory + - + + + + - - - - - - 
7. Chronic Pain Coping Inventory + - + + + + - - + - + - 
8. Survey of Pain Attitudes + + + + + - - - - - - - 
9. German Pain Management Strategies + - - + + + + - - - - - 
10. Psychological Empowerment Scale - - - - + + + - - - - - 
11. Swedish Rheumatic Disease Empowerment Scale - - - + + + - - - - - - 
12. Appraisal of Self-Care Agency Scale - - + - - - - - - - + - 
13. Health Education Impact Questionnaire + - + + + + - + + - + - 
14. Inventory of Adult Role Behaviours - - + - - - - + + + - - 
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Table 6: Quality criteria of the identified measures following Terwee (modified) [20] 
 Measures  
(target population) 
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1
. 
Arthritis Self-efficacy Scale  
(Patients with arthritis) 
[51,52
] 
+ + + 0 ? 0 0 0 
2
. 
Self-Efficacy Scale  
(All patients) 
[51,52
] 
+ + + 0 ? 0 0 0 
3
. 
Pain Self Efficacy Questionnaire  
(Patients with pain) 
[53,76
,77] 
+ + + 0 ? 0 - ? 
4
. 
Chronic Pain Self-Efficacy Scale  
(Patients with chronic pain) 
[54] + + + 0 + - 0 0 
5
. 
Coping Strategies Questionnaire  
(All patients) 
[59] - - - 0 0 0 0 0 
6
. 
Pain Coping Inventory  
(Patients with pain) 
[60] - - - 0 - 0 0 0 
7
. 
Survey of Pain Attitudes  
(Patients with pain) 
[63,64
,78] 
+ - ? 0 0 0 0 0 
8
. 
Chronic Pain Coping Inventory  
(Patients with chronic pain) 
[62,79
,80] 
+ + + 0 0 0 0 0 
9
. 
Psychological Empowerment 
Scale  
(All patients) 
[67,81
] 
? + ? 0 0 0 0 0 
1
0
. 
Swedish Rheumatic Disease 
Empowerment Scale  
(Patients with rheumatoid 
arthritis) 
[70] + - - 0 0 0 - ? 
1
1
. 
Appraisal of Self-Care Agency 
Scale  
(All patients) 
[72,82
] 
? + - 0 0 0 0 0 
1
2 
Health Education Impact 
Questionnaire  
(Patients with chronic conditions) 
[73,83
] 
+ + + 0 0 0 0 0 
1
3
. 
Inventory of Adult Role 
Behaviours  
(All patients) 
[74,75
] 
- + - 0 0 0 0 0 
+ = positive, ? = intermediate, - = negative, 0 = no information available; German Pain 
Management Strategies was not appraised as the paper is not in English 
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